CPT® Code 82480

1. Indications

The cholinesterase serum test (CPT® Code 82480) is indicated for several specific clinical scenarios, including:

• Accidental Exposure to Organic Phosphates This test is performed to evaluate potential exposure to organic phosphates, which are chemicals often found in pesticides that can adversely affect the nervous system.
• Inherited Pseudocholinesterase Deficiency The test is used to identify individuals who may have an inherited deficiency of pseudocholinesterase, placing them at risk for prolonged paralysis when succinylcholine, a neuromuscular blocking agent, is administered during surgical procedures or anesthesia.
• Diagnosis of Liver Disease Although less common, the cholinesterase test may also be utilized to assist in the diagnosis of liver disease, as liver function can impact enzyme levels in the serum.

2. Procedure

The procedure for conducting the cholinesterase serum test involves several key steps:

• Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or substances that could interfere with the results. It is essential to ensure that the patient is adequately informed about the procedure.
• Step 2: Venipuncture A qualified healthcare professional performs a venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to draw blood into a collection tube. The venipuncture is a separately reportable procedure and must be documented accordingly.
• Step 3: Sample Processing Once the blood sample is collected, it is processed in a laboratory setting. The serum or red blood cells are separated from the other components of the blood for analysis.
• Step 4: Enzymatic Testing The laboratory conducts qualitative enzymatic testing on the serum or red blood cells to measure the activity levels of cholinesterase. This analysis provides the necessary data to assess the patient's cholinesterase levels.

3. Post-Procedure

After the cholinesterase serum test is completed, the patient may be monitored for any immediate reactions to the venipuncture, although complications are rare. The results of the test will be analyzed and reported to the healthcare provider, who will interpret the findings in the context of the patient's clinical situation. If the test indicates abnormal cholinesterase levels, further evaluation or intervention may be necessary, depending on the underlying reason for the testing. Patients should be informed about when to expect results and any follow-up actions that may be required based on those results.